Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

79.70

-3.47 (-4.17%)

At close: Oct 21, 2026, 4:00 PM EDT

79.26

-0.44 (-0.55%)

After-hours: Oct 21, 2026, 4:47 PM EDT

KNSA Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	6,219	3,127	1,428	1,234	1,042	811
Market Cap Growth	117.16%	118.92%	15.76%	18.45%	28.46%	-32.59%
Enterprise Value	5,701	2,784	1,215	1,046	848	617
Last Close Price	83.17	41.25	19.78	17.54	14.98	11.77

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	80.48	52.99	-	87.60	5.68	-
Forward PE	56.03	27.32	42.93	170.84	170.84	-
PS Ratio	7.38	4.61	3.37	4.57	4.73	21.04
PB Ratio	9.91	5.51	3.26	2.81	2.63	4.38
P/TBV Ratio	9.71	5.66	3.38	2.93	2.76	4.89
P/FCF Ratio	33.96	22.92	56.20	93.67	182.67	-
P/OCF Ratio	33.57	22.66	55.59	92.76	179.37	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	6.77	4.11	2.87	3.87	3.85	16.02
EV/EBITDA Ratio	55.78	35.34	-	-	69.62	-
EV/EBIT Ratio	56.77	36.06	-	-	86.73	-
EV/FCF Ratio	31.13	20.41	47.81	79.39	148.64	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.02	0.02	0.03	0.02	0.03
Debt / EBITDA Ratio	0.08	0.11	-	-	0.38	-
Debt / FCF Ratio	0.05	0.07	0.39	0.93	1.04	-
Net Debt / Equity Ratio	-0.79	-0.71	-0.53	-0.44	-0.47	-0.95
Net Debt / EBITDA Ratio	-5.07	-5.14	5.32	8.49	-15.17	1.14
Net Debt / FCF Ratio	-2.83	-2.97	-9.20	-14.74	-32.39	1.39
Asset Turnover	1.08	1.01	0.77	0.55	0.64	0.13
Inventory Turnover	6.42	7.56	6.58	3.41	3.72	-
Quick Ratio	3.21	3.09	2.84	3.58	4.48	4.15
Current Ratio	3.90	3.79	3.30	4.34	5.16	4.38
Return on Equity (ROE)	14.04%	11.73%	-9.85%	3.37%	63.10%	-63.55%
Return on Assets (ROA)	8.05%	7.18%	-5.15%	-3.19%	1.76%	-33.63%
Return on Invested Capital (ROIC)	49.89%	27.89%	-20.30%	-11.05%	8.87%	-7244.96%
Return on Capital Employed (ROCE)	13.80%	12.40%	-9.50%	-5.40%	2.40%	-83.30%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.24%	1.89%	-3.02%	1.14%	17.60%	-19.48%
FCF Yield	2.95%	4.36%	1.78%	1.07%	0.55%	-15.63%
Buyback Yield / Dilution	-9.97%	-10.58%	0.69%	-2.13%	-2.69%	-10.89%

SEC Filings: 10-K · 10-Q